thyroxine has been researched along with Scleroderma, Limited in 1 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
Scleroderma, Limited: The least progressive form of SYSTEMIC SCLERODERMA with skin thickening restricted to the face, neck and areas distal to the elbows and/or knees, sparing the trunk. The CREST SYNDROME is a form of limited scleroderma.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although Graves' disease and systemic sclerosis are both autoimmune disorders, their relationship is rarely reported." | 1.46 | Limited cutaneous systemic sclerosis arising in a patient with Graves' disease. ( Quisumbing, JP; Yu, MG, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yu, MG | 1 |
| Quisumbing, JP | 1 |
1 other study available for thyroxine and Scleroderma, Limited
| Article | Year |
|---|---|
Limited cutaneous systemic sclerosis arising in a patient with Graves' disease.
Topics: Adult; Antithyroid Agents; Facial Dermatoses; Female; Graves Disease; Hormone Replacement Therapy; H | 2017 |